Dronabinol 5mg Cap
1 QAM and 2 QHS PO 14 days
Loading study record…
This study is designed to investigate the effect of dronabinol on post operative pain in patients undergoing total knee replacement (for their own clinical care).
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2023-11-13
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Total knee replacement is a common surgical procedure that restores function to the damaged joint. Recovery from this procedure takes weeks and requires opioids to manage post-surgical pain. The goal of this study is to investigate whether dronabinol (synthetic THC) can reduce pain and the need for opioid medication following this particular surgery. Subjects will be recruited from the Department of Orthopedic Surgery. All subjects will undergo total knee replacement as part of their clinical care (the surgery itself is not part of this study). The study begins following discharge from the hospital. They will be asked to take dronabinol or placebo as they recover from surgery. During this time they will be given their usual pain medications at discharge which includes opioids for pain. The opioids are to be taken if the subject is experiencing pain. The investigator's hypothesis is that subjects taking dronabinol will need fewer doses of opioids to control pain.
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Interventions
1 QAM and 2 QHS PO 14 days
1 QAM and 2 QHS PO 14 days
Eligibility
primary outcomes
Time frame: 2 weeks
pain assessment, self report measure of pain, scale 0-10 (10 worst)
secondary outcomes
Time frame: two weeks
opioid use by participant for pain after surgery
Publications
No exact PMID-linked public article is currently readable locally.